The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?

Bull Urooncol 2014;13(2):103-108

DOI: 10.4274/UOB.09

1. Namik Kemal Üniversitesi Tip Faku¨Ltesi, Üroloji Anabilim Dali, Tekirdag, Tu¨Rkiye

2. Marmara Üniversitesi Tip Faku¨Ltesi, Üroloji Anabilim Dali, Istanbul, Tu¨Rkiye

No information available.

No information available

PDF

Cite

Request

ABSTRACT

Bacillus Calmette Guérin (BCG), is the optimal bladder-sparing treatment option for patients with high-risk, non-muscle invasive bladder cancer. Recently, the application of BCG has been hindered due to the problem of its availability in Turkey. Alternative treatment options are needed until this problem is solved. In this article, the recommendations about the preferred treatment options and the follow-up, are summarized in the light of the current literature. (Bulletin of Urooncology 2014;13:103-108)